亚宝药业披露股份回购进展，累计回购600万股

Core Points - The company announced a share repurchase plan approved at the shareholders' meeting on May 16, 2025, with a repurchase period from May 16, 2025, to November 14, 2025 [1] - The expected repurchase amount is between 50 million to 100 million yuan, aimed at reducing registered capital [1] - As of September 30, the company has repurchased a total of 6 million shares, accounting for 0.86% of the total share capital, with a maximum transaction price of 6.65 yuan per share and a minimum of 6.30 yuan per share, totaling a payment of 38,878,040 yuan [1]